Exploring High Insider Ownership Growth Stocks On Euronext Paris

Amid a backdrop of cautious optimism in European markets, with France's CAC 40 Index showing modest gains, investors are increasingly attentive to growth opportunities within the Euronext Paris. High insider ownership in growth companies often signals strong confidence from those who know the business best, making such stocks potentially attractive in the current economic environment where discerning value is key.

Top 10 Growth Companies With High Insider Ownership In France

Name	Insider Ownership	Earnings Growth
VusionGroup (ENXTPA:VU)	13.5%	25.2%
Groupe OKwind Société anonyme (ENXTPA:ALOKW)	24.8%	30.6%
WALLIX GROUP (ENXTPA:ALLIX)	19.8%	101.4%
La Française de l'Energie (ENXTPA:FDE)	20.1%	37.7%
Adocia (ENXTPA:ADOC)	12.1%	104.5%
OSE Immunotherapeutics (ENXTPA:OSE)	24.9%	79.3%
Icape Holding (ENXTPA:ALICA)	30.2%	26.1%
Arcure (ENXTPA:ALCUR)	21.4%	41.7%
Munic (ENXTPA:ALMUN)	29.4%	150%
MedinCell (ENXTPA:MEDCL)	16.4%	68.8%

Click here to see the full list of 22 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Here we highlight a subset of our preferred stocks from the screener.

MedinCell

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a French pharmaceutical company that specializes in developing long-acting injectable medications across multiple therapeutic areas, with a market capitalization of approximately €439.40 million.

Operations: The company generates its revenue primarily from the pharmaceuticals segment, totaling €14.13 million.

Insider Ownership: 16.4%

MedinCell, a French pharmaceutical company, showcases significant growth potential with its innovative long-acting injectable technologies. Despite recent setbacks in clinical trials, such as the Phase 3 trial of F14 not meeting its primary endpoint, MedinCell reported promising improvements in secondary outcomes and safety profiles. The company's collaboration with major industry players like AbbVie and Teva indicates robust pipeline prospects and potential revenue streams. However, high share price volatility and past shareholder dilution present risks. MedinCell's revenue is forecasted to grow substantially at 40.1% per year, outpacing the French market average.

• Get an in-depth perspective on MedinCell's performance by reading our analyst estimates report here.

• According our valuation report, there's an indication that MedinCell's share price might be on the cheaper side.

ENXTPA:MEDCL Ownership Breakdown as at Jun 2024

OVH Groupe

Simply Wall St Growth Rating: ★★★★☆☆

Overview: OVH Groupe S.A. is a global provider of public and private cloud services, shared hosting, and dedicated server solutions, with a market capitalization of approximately €1.04 billion.

Operations: The company generates revenue from three main segments: Public Cloud (€140.71 million), Private Cloud (€514.59 million), and Web Cloud (€179.45 million).

Insider Ownership: 10.5%

OVH Groupe, a French cloud services provider, is navigating its growth trajectory with significant executive enhancements and strategic expansions. Recently appointing Celine Choussy and promoting Yaniv Fdida to bolster its marketing and technology leadership, the company aims to enhance its global footprint and innovation capabilities. Despite a volatile share price, OVH has shown resilience by reducing net losses significantly in the first half of 2024 (EUR 17.24 million from EUR 26.59 million). Moreover, the opening of a new data center in Canada underscores its commitment to expanding infrastructure and boosting performance metrics across North America. While insider ownership remains stable without recent substantial buying or selling, OVH's forecasted revenue growth at 11.1% per year outstrips the French market projection of 5.8%, although it trails behind higher industry benchmarks.

• Dive into the specifics of OVH Groupe here with our thorough growth forecast report.

• According our valuation report, there's an indication that OVH Groupe's share price might be on the expensive side.

ENXTPA:OVH Ownership Breakdown as at Jun 2024

VusionGroup

Simply Wall St Growth Rating: ★★★★★★

Overview: VusionGroup S.A. is a company that offers digitalization solutions for commerce across Europe, Asia, and North America, with a market capitalization of approximately €2.34 billion.

Operations: The company generates revenue primarily through the installation and maintenance of electronic shelf labels, amounting to €801.96 million.

Insider Ownership: 13.5%

VusionGroup S.A. has demonstrated robust growth with its full-year earnings for 2023 showing a substantial increase, reporting sales of €801.96 million and net income of €79.77 million, reflecting significant year-over-year improvements. The company's earnings per share also saw a sharp rise from the previous year. Analysts expect VusionGroup's revenue and earnings to outpace the French market significantly over the next few years, forecasting annual revenue growth at 21.9% and profit growth at 25.2%. Despite this positive outlook, the stock remains volatile and is currently trading below analyst price targets by 29.3%.

• Take a closer look at VusionGroup's potential here in our earnings growth report.

• Insights from our recent valuation report point to the potential overvaluation of VusionGroup shares in the market.

ENXTPA:VU Ownership Breakdown as at Jun 2024

Where To Now?

• Navigate through the entire inventory of 22 Fast Growing Euronext Paris Companies With High Insider Ownership here.

• Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.

• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include ENXTPA:MEDCLENXTPA:OVHENXTPA:VU and

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com